ETF PM is currently working to protect client portfolios as follows: We have been encouraging clients with a growth asset allocation to shift
Hedging Biotech Risk (1/16)
Over the past five years, the biotech ETF (IBB) delivered a total return of roughly 200%, three times the S&P 500's total return of 60%.